Moksha8
2007
FOUNDED
PRIVATE
STATUS
201-300
EMPLOYEES
Mezzanine
LATEST DEAL TYPE
$25M
LATEST DEAL AMOUNT
6
INVESTORS
Description
Developer of therapeutics designed to provide treatment for mental health disorders. The company's therapeutics focuses on commercializing the medicines in class operations and strong FCPA compliance, enabling patients to start begin treatment more quickly and result in a higher likelihood of a successful treatment.
Website
Ownership Status
Privately Held (backing)
Financing Status
Venture Capital-Backed
Primary Industry
Therapeutic Devices
Other Industries
Pharmaceuticals
Primary Office
- Avenue Ibirapuera, 2332
- Tower1 - 13th floor Indianópolis
- Sao Paulo, 04028
- Brazil
+55 (11) 0000-0000
Request full access to PitchBook
You’re viewing a free company profile from the PitchBook Platform. To explore Moksha8’s full profile, request a free trial.
Moksha8 Valuation and Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 10. Mezzanine | 15-Feb-2019 | $25M | 00000 | Completed | Generating Revenue | |
| 9. Later Stage VC | 06-Jan-2014 | 00000 | Cancelled | Generating Revenue | ||
| 8. Secondary Transaction - Private | 22-Oct-2012 | 000.00 | 00000 | 000.00 | Completed | Generating Revenue |
| 7. Later Stage VC (Series 3) | 14-Oct-2010 | 0000 | 00000 | 00000 | Completed | Startup |
| 6. Convertible Debt | 10-Jun-2010 | 00.00 | 000.00 | Completed | Startup | |
| 5. Later Stage VC (Series 2) | 01-Dec-2009 | 000.00 | 000.00 | 000.00 | Completed | Startup |
| 4. Convertible Debt | 05-Nov-2009 | 000 | 000.00 | Completed | Startup | |
| 3. Convertible Debt | 11-Feb-2009 | 00.000 | 000.00 | Completed | Startup | |
| 2. Early Stage VC (Series B) | 30-Jan-2008 | $15M | $39M | Completed | Startup | |
| 1. Early Stage VC (Series A) | 30-Jan-2008 | $24M | $24M | Completed | Startup |
Moksha8 Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price |
% Owned |
|---|---|---|---|---|---|---|---|---|
| Series 3a | 00,000,000 | 00.000000 | 0.00 | 00.0 | 00.0 | 00 | 00.0 | 00.000 |
| Series 3a | 00,000,000 | 00.000000 | 0.00 | 00.00 | 00.00 | 00 | 00.00 | 0.000 |
| Series 2 | 00,000,000 | 00.000000 | 0.00 | 00.00 | 00.00 | 00 | 00.00 | 00.000 |
| Series 1a | 1,858,968 | $0.001000 | 9.5% | $3.29 | $3.29 | 1x | $3.29 | 1.25% |
| Series 1 | 18,706,466 | $0.001000 | 9.5% | $0.9 | $0.9 | 1x | $0.9 | 12.59% |
Moksha8 Investors (6)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds | Board Seat |
Contact Info |
|---|---|---|---|---|---|---|
| Knight Therapeutics | Corporation | Minority | 000 0000 | 000000 0 | ||
| Votorantim New Business | Corporate Venture Capital | Minority | 000 0000 | 000000 0 | ||
| Montreux Equity Partners | Growth/Expansion | Minority | 000 0000 | 000000 0 | ||
| GVK BIO | VC-Backed Company | Minority | 000 0000 | 000000 0 | ||
| Lit Tele | Corporation | Minority | 000 0000 | 000000 0 |
Moksha8 Executive Team (15)
10 Former Executives
You’re viewing 5 of 15 executives. Get the full list »Moksha8 Board Members (13)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| Arthur Higgins | Self | Board Member | 000 0000 | |
| Daniel Turner III | Montreux Equity Partners | Board Member | 000 0000 | |
| David Solomon JD | Forest Laboratories | Board Member | 000 0000 | |
| Joel Barlan | Moksha8 | Chief Executive Officer & Board Member | 000 0000 | |
| Mariano García-Valiño | Moksha8 | Chairman | 000 0000 |
6 Former Board Members
You’re viewing 5 of 13 board members. Get the full list »